Sabby Management’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-161,930
Closed -$4.81K 55
2024
Q4
$4.81K Sell
161,930
-109,198
-40% -$3.16K 0.01% 27
2024
Q3
$15.5K Sell
271,128
-24,461
-8% -$1.41K 0.01% 33
2024
Q2
$20.7K Sell
295,589
-11,128
-4% -$1.03K 0.01% 34
2024
Q1
$23.3K Hold
306,717
0.01% 45
2023
Q4
$12.3K Hold
306,717
0.01% 50
2023
Q3
$107K Buy
+306,717
New +$132K 0.08% 48

Other funds holding SXTPW

Sabby Management's SXTPW Position: Q1 2025 in Review

Sabby Management sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q1 2025, closing a stake of 161,930 shares — an estimated $4.81K sold.

Sabby Management first reported a position in SXTPW in Q3 2023 and held it in 6 quarters. The position peaked at $107K in Q3 2023. 6 funds tracked by Wall St. Rank hold SXTPW as of Q1 2025.

  • Sabby Management reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q1 2025 after selling out during the quarter.
  • Sabby Management sold 161,930 60 Degrees Pharmaceuticals Warrant shares in Q1 2025, an estimated $4.81K.
  • Sabby Management first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and held it in 6 quarters.
  • Sabby Management's 60 Degrees Pharmaceuticals Warrant position peaked at $107K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2025.

Based on Sabby Management's 13F filing for Q1 2025, filed 15 May 2025.